COVID-19 Therapeutics for Nonhospitalized Patients-Updates and Future Directions

Kara W Chew; Preeti N Malani; Rajesh T Gandhi

doi:10.1001/jama.2023.19542

COVID-19 Therapeutics for Nonhospitalized Patients-Updates and Future Directions

JAMA. 2023 Oct 24;330(16):1519-1520. doi: 10.1001/jama.2023.19542.

Authors

Kara W Chew¹, Preeti N Malani^{2

3}, Rajesh T Gandhi⁴

Affiliations

¹ Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles, Los Angeles.
² Department of Internal Medicine, Division of Infectious Diseases, University of Michigan, Ann Arbor.
³ Deputy Editor, JAMA.
⁴ Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston.

PMID: 37773595
DOI: 10.1001/jama.2023.19542

No abstract available

Plain language summary

In this Viewpoint, the authors summarize the therapeutic landscape for COVID-19, discuss who is most likely to benefit from treatment, provide an update on managing illness in immunocompromised individuals, and highlight how to improve COVID-19 treatment.